Brian J Nickerson, PhD, JD
- PROFESSOR | Population Health Science and Policy
- SENIOR ASSOCIATE DEAN FOR MASTER'S PROGRAMS
Brian J. Nickerson, PhD, has over 20 years of multi-faceted experience in academic institutions, including 15 years in senior management positions ranging from Director, Department Chair, Academic Dean, to Senior Vice President. Dr. Nickerson has launched over 20 successful programs or institutes in his career, many of which were “first-of-its kind”. He currently serves as the Senior Associate Dean for Master’s Programs in the Graduate School of Biomedical Sciences, Director for the Health Care Delivery Leadership Program, and Professor in the Department of Population Health Science & Policy. He is responsible for related academic program development and management, digital learning, and academic partnerships.
Professor Nickerson has been teaching undergraduate and graduate students since 1993 and has produced a large body of visible action research appearing in domestic and international publications and forming the basis for changes in public policy, including healthcare issues. Moreover, he has been a frequent guest commentator on critical policy and political questions for several media outlets including The New York Times, National Public Radio, ABC News, and CBS News, as well as others.
Professor Nickerson has earned his PhD from the Rockefeller College of the State University of New York at Albany, a Juris Doctor and an MPA from Pace University, and his BA from Iona College.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Nickerson did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.